Prevalence and genotype distribution of HPV infection from Hangzhou of Zhejiang Province pre- and during COVID-19 pandemic.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE
    • Publication Information:
      Original Publication: Lausanne : Frontiers Editorial Office
    • Subject Terms:
      COVID-19*/epidemiology ; COVID-19*/virology ; Papillomavirus Infections*/epidemiology ; Papillomavirus Infections*/virology ; Genotype* ; Papillomaviridae*/genetics ; Papillomaviridae*/isolation & purification; Humans ; Female ; China/epidemiology ; Male ; Prevalence ; Middle Aged ; Adult ; Aged ; Young Adult ; SARS-CoV-2/genetics ; Adolescent ; Pandemics/statistics & numerical data
    • Abstract:
      Limited data exist on HPV prevalence and genotyping during the COVID-19 pandemic. A total of 130,243 samples from 129, 652 women and 591 men who visited the First People's Hospital of Linping District between 2016 and 2022 were recruited. HPV genotypes were detected by polymerase chain reaction (PCR) amplification and nucleic acid molecular hybridization. Then the prevalence characteristics of HPV genotypes and trends in HPV infection rates from 2016 to 2022 were analyzed. Results showed that among the study population, the overall prevalence of HPV infection was 15.29%, with 11.25% having single HPV infections and 4.04% having multiple HPV infections, consistent with previous findings. HPV genotypes exhibited similar distribution patterns in both male and female groups, with HPV16, HPV52, HPV58, HPV18, and HPV39 being the most prevalent. Age-related analysis unveiled a bimodal pattern in HPV prevalence, with peaks in infection rates observed in individuals below 20 and those aged 61-65 years. Comparing the pre- and during COVID-19 periods revealed significant disparities in HPV infections, with variations in specific HPV genotypes, including 16, 18, 35, 45, 52, 58, 59, and 68. This study provides valuable insights into the prevalence, distribution, and epidemiological characteristics of HPV infections in a large population. It also highlights the potential impact of the COVID-19 pandemic on HPV trends.
      Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
      (Copyright © 2024 Wang, Zhao, Xia, He, Chen, Wang, Ma and Sun.)
    • References:
      Br J Cancer. 2006 Jul 3;95(1):96-101. (PMID: 16773069)
      Front Microbiol. 2023 Jan 04;13:1094560. (PMID: 36687652)
      Cancer Med. 2022 Nov;11(22):4366-4373. (PMID: 35365956)
      Front Public Health. 2021 Jan 20;8:552028. (PMID: 33553082)
      Sci Rep. 2022 Aug 3;12(1):13353. (PMID: 35922661)
      Virol J. 2010 Mar 23;7:66. (PMID: 20307327)
      Emerg Microbes Infect. 2016 Nov 23;5(11):e119. (PMID: 27876782)
      Front Public Health. 2022 Jul 08;10:890880. (PMID: 35875040)
      Virol J. 2021 Oct 20;18(1):208. (PMID: 34670576)
      Nat Rev Microbiol. 2022 Feb;20(2):95-108. (PMID: 34522050)
      Cancer Med. 2019 Sep;8(11):5373-5385. (PMID: 31350872)
      Int J Infect Dis. 2021 Oct;111:295-302. (PMID: 34343706)
      Semin Cancer Biol. 2014 Jun;26:13-21. (PMID: 24316445)
      Am Fam Physician. 2021 Aug 1;104(2):152-159. (PMID: 34383440)
      Sci Rep. 2016 Feb 12;6:21039. (PMID: 26868772)
      BMC Infect Dis. 2018 May 3;18(1):204. (PMID: 29724192)
      N Engl J Med. 2003 Feb 6;348(6):518-27. (PMID: 12571259)
      J Med Virol. 2022 Jun;94(6):2787-2795. (PMID: 34859449)
      Cancer Biol Med. 2020 Nov 15;17(4):864-878. (PMID: 33299640)
      Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9714-9720. (PMID: 31799637)
      Lancet Glob Health. 2023 Sep;11(9):e1345-e1362. (PMID: 37591583)
      J Med Virol. 2016 Mar;88(3):532-40. (PMID: 26266484)
      Zhonghua Nan Ke Xue. 2018 Sep;24(9):795-801. (PMID: 32212457)
      Nat Rev Cancer. 2002 May;2(5):342-50. (PMID: 12044010)
      Head Neck. 2015 Nov;37(11):1625-32. (PMID: 24955561)
      Front Med (Lausanne). 2021 Sep 20;8:676401. (PMID: 34616752)
    • Contributed Indexing:
      Keywords: COVID-19; China; genotype; human papillomavirus; prevalence
    • Publication Date:
      Date Created: 20240614 Date Completed: 20240614 Latest Revision: 20240615
    • Publication Date:
      20240615
    • Accession Number:
      PMC11169856
    • Accession Number:
      10.3389/fpubh.2024.1357311
    • Accession Number:
      38873306